ENCORE: A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 2

Dr. Hoffman continues his conversation with Dr. James Min, an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has developed an improved scan that can differentiate between dangerous unstable plaque, and more benign lesions.